Factors Affecting Health-related Quality of Life in Thai Children with Thalassemia

Overview

Journal BMC Blood Disord

Publisher Biomed Central

Specialty Hematology

Date 2010 Feb 26

PMID 20180983

Citations 41

Authors

Montarat Thavorncharoensap

Kitti Torcharus

Issarang Nuchprayoon

Arthorn Riewpaiboon

Kaemthong Indaratna

Bang-On Ubol

Affiliations

Soon will be listed here.

Abstract

Background: Knowledge of the factors associated with health-related quality of life (HRQOL) among patients with thalassemia is essential in developing more suitable clinical, counseling, and social support programs to improve treatment outcomes of these patients. In light of the limited research in this area, this study aims to examine factors associated with HRQOL among children and adolescents with thalassemia in Thailand.

Methods: A cross-sectional survey was conducted in three selected hospitals in Thailand during June to November 2006. PedsQL 4.0 Generic Core Scale (Thai version) was used to assess HRQOL in 315 thalassemia patients between 5 and 18 years of age. Other related clinical characteristics of the patients were collected via medical record review.

Results: The mean (SD) of the total summary score was 76.67 (11.40), while the means (SD) for the Physical Health Summary score and Psychosocial Health Summary score were 78.24 (14.77) and 75.54 (12.76), respectively. The school functioning subscale scored the lowest, with a mean of 67.89 (SD = 15.92). The following factors significantly affected the HRQOL of the patients: age; age at onset of anemia and age at first transfusion; pre-transfusion hemoglobin (Hb) level; receiving a blood transfusion during the previous three months; and disease severity. In addition, iron chelation therapy had a significant negative effect on HRQOL in the school functioning subscale. In contrast, serum ferritin level, frequency of blood transfusions per year, and gender were not significantly related to HRQOL among these patients. The results from multivariate analysis also confirmed these findings.

Conclusions: To improve HRQOL of thalassemia patients, suitable programs aimed at providing psychosocial support and a link between the patient, school officials, the family and the physician are important, especially in terms of improving the school functioning score. The findings also confirmed the importance of maintaining a pre-transfusion Hb level of at least 9-10.5 g/dL. In addition, special care and attention should be given to patients with a severe condition, and those who are receiving subcutaneous iron chelation therapy.

Citing Articles

Assessing the Quality of Life of Parents of Children With Thalassemia: A Cross-Sectional Study in Medina City, Saudi Arabia.

Tobaiqi M, Aljohani A, Alharbi F, Alshenqiti U, Alahmadi N, Abdelrahman M Cureus. 2024; 16(10):e71653.

PMID: 39553145 PMC: 11567692. DOI: 10.7759/cureus.71653.

Hameed Z, Hassan M, Ahmed B Cureus. 2024; 16(9):e70189.

PMID: 39463582 PMC: 11508038. DOI: 10.7759/cureus.70189.

Effectiveness of educational intervention on quality of life in adults with thalassemia major: A quasi-experimental study based on PRECEDE model.

Hassani L, Seyrafi N, Mohammadi S, Aghamolaei T, Ghanbarnejad A, Reza Evazi M Health Sci Rep. 2024; 7(9):e70075.

PMID: 39319249 PMC: 11420465. DOI: 10.1002/hsr2.70075.

Factors Associated With Quality of Life Among Adolescent With Beta Thalassemia in Indonesia: A Cross-Sectional Study.

Mardhiyah A, Panduragan S, Mediani H, Yosep I SAGE Open Nurs. 2024; 10:23779608241255638.

PMID: 39109385 PMC: 11301742. DOI: 10.1177/23779608241255638.

Systematic review and evidence gap assessment of the clinical, quality of life, and economic burden of alpha-thalassemia.

Musallam K, Viprakasit V, Lombard L, Gilroy K, Rane A, Vinals L EJHaem. 2024; 5(3):541-547.

PMID: 38895066 PMC: 11182398. DOI: 10.1002/jha2.882.

References

Zurlo M, De Stefano P, Borgna-Pignatti C, Di Palma A, Piga A, Melevendi C . Survival and causes of death in thalassaemia major. Lancet. 1989; 2(8653):27-30. DOI: 10.1016/s0140-6736(89)90264-x. View

Cianciulli P . Treatment of iron overload in thalassemia. Pediatr Endocrinol Rev. 2009; 6 Suppl 1:208-13. View

Cao A . Quality of life and survival of patients with beta-thalassemia major. Haematologica. 2004; 89(10):1157-9. View

Telfer P, Constantinidou G, Andreou P, Christou S, Modell B, Angastiniotis M . Quality of life in thalassemia. Ann N Y Acad Sci. 2005; 1054:273-82. DOI: 10.1196/annals.1345.035. View

Sripichai O, Makarasara W, Munkongdee T, Kumkhaek C, Nuchprayoon I, Chuansumrit A . A scoring system for the classification of beta-thalassemia/Hb E disease severity. Am J Hematol. 2008; 83(6):482-4. DOI: 10.1002/ajh.21130. View

Musallam K, Cappellini M, Taher A . Challenges associated with prolonged survival of patients with thalassemia: transitioning from childhood to adulthood. Pediatrics. 2008; 121(5):e1426-9. DOI: 10.1542/peds.2007-1944. View

McGlynn E, Halfon N, Leibowitz A . Assessing the quality of care for children. Prospects under health reform. Arch Pediatr Adolesc Med. 1995; 149(4):359-68. DOI: 10.1001/archpedi.1995.02170160013002. View

Wanapirak C, Tongsong T, Sirivatanapa P, Sekararithi R, Tuggapichitti A . Prenatal strategies for reducing severe thalassemia in pregnancy. Int J Gynaecol Obstet. 1998; 60(3):239-44. DOI: 10.1016/s0020-7292(97)00271-3. View

Dubey A, Parakh A, Dublish S . Current trends in the management of beta thalassemia. Indian J Pediatr. 2008; 75(7):739-43. DOI: 10.1007/s12098-008-0140-4. View

10.

Caro J, Ward A, Green T, Huybrechts K, Arana A, Wait S . Impact of thalassemia major on patients and their families. Acta Haematol. 2002; 107(3):150-7. DOI: 10.1159/000057633. View

11.

Varni J, Seid M, Kurtin P . PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001; 39(8):800-12. DOI: 10.1097/00005650-200108000-00006. View

12.

Mikelli A, Tsiantis J . Brief report: Depressive symptoms and quality of life in adolescents with b-thalassaemia. J Adolesc. 2004; 27(2):213-6. DOI: 10.1016/j.adolescence.2003.11.011. View

13.

Abetz L, Baladi J, Jones P, Rofail D . The impact of iron overload and its treatment on quality of life: results from a literature review. Health Qual Life Outcomes. 2006; 4:73. PMC: 1592476. DOI: 10.1186/1477-7525-4-73. View

14.

Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini M, Del Vecchio G . Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004; 89(10):1187-93. View

15.

Santos P, Kerr L . Clinical and laboratory variables associated with quality of life in Brazilian haemodialysis patients: a single-centre study. Rev Med Chil. 2009; 136(10):1264-71. DOI: /S0034-98872008001000005. View

16.

Weatherall D . 2003 William Allan Award address. The Thalassemias: the role of molecular genetics in an evolving global health problem. Am J Hum Genet. 2004; 74(3):385-92. PMC: 1182250. DOI: 10.1086/381402. View

17.

Seid M, Varni J, Segall D, Kurtin P . Health-related quality of life as a predictor of pediatric healthcare costs: a two-year prospective cohort analysis. Health Qual Life Outcomes. 2004; 2:48. PMC: 521194. DOI: 10.1186/1477-7525-2-48. View

18.

Afsar B, Ozdemir N, Sezer S, Haberal M . Quality of life is not related with liver disease severity but with anemia, malnutrition, and depression in HCV-infected hemodialysis patients. Hemodial Int. 2009; 13(1):62-71. DOI: 10.1111/j.1542-4758.2009.00329.x. View

19.

Pongwilairat K, Louthrenoo O, Charnsil C, Witoonchart C . Quality of life of children with attention-deficit/hyper activity disorder. J Med Assoc Thai. 2006; 88(8):1062-6. View

20.

Porter J, Davis B . Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia. Best Pract Res Clin Haematol. 2002; 15(2):329-68. View